Genius Sports Limited (GENI) Stock Price & Analysis
Genius Sports Limited (GENI) closed at USD 6.54 on Thursday, October 22, 2026, up 1.71% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 6.43; the Oct 22, 2026 session ranged USD 6.32–6.75 on volume of 5,221,363 shares. Market capitalization is $1.75B, with a 52-week range of USD 3.83–12.17 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:00 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GENI.md
Key facts (GENI)
- 1 of 80 tracked superinvestors hold GENI (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $5.6M; 2 not under a Rule 10b5-1 plan ($5.6M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (21 analysts), mean target USD 10.83 (range 6–20).
- Total return with dividends: 1Y -45.5% vs S&P 500 +14.9%; 5Y -64.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-03, EPS estimate USD 0.2, revenue estimate $261M.
Superinvestors (SEC 13F-HR, Q2 2026) (GENI)
1 of 80 tracked investors hold GENI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Samantha McLemore | Patient Capital Management | 0.16% | $4.9M | New position |
Insider sales (SEC Form 4, open-market, last ~7 months) (GENI)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Russell Thomas | Chief Legal Officer | 50,000 | $326K | 9.6% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-15…2026-09-17 | Locke Mark | Chief Executive Officer | 800,000 | $5.3M | 4% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (GENI)
Consensus Buy (mean 2.00 on a 1–5 scale), 21 analysts; mean target USD 10.83 (low 6, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | Macquarie | Target lowered | Outperform | $12 → $11 |
| 2026-09-25 | JP Morgan | Initiated | Overweight | $8 |
| 2026-08-07 | Guggenheim | Target raised | Buy | $11 → $12 |
| 2026-08-07 | Macquarie | Target raised | Outperform | $10 → $12 |
| 2026-08-07 | Oppenheimer | Target raised | Outperform | $10 → $12 |
| 2026-08-07 | Needham | Target raised | Buy | $10 → $12 |
| 2026-08-07 | Wells Fargo | Downgrade | Overweight → Equal-Weight | $8 |
| 2026-08-06 | BTIG | Target raised | Buy | $9 → $10 |
| 2026-07-31 | Oppenheimer | Target raised | Outperform | $9 → $10 |
| 2026-07-22 | Stifel | Target raised | Hold | $5 → $7 |
| 2026-07-20 | Wells Fargo | Target lowered | Overweight | $9 → $8 |
| 2026-07-20 | Freedom Capital Markets | Initiated | Buy | $9 |
Total return (dividends reinvested) (GENI)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -45.5% | -64.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -45.6% | -18.4% |
| Volatility (annualized) | 74.5% | 66.2% |
| Max drawdown | -67.4% (Oct 2025→Apr 2026) | -86.8% (Oct 2021→Jul 2022) |
GENI suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | US | “Our business and operating results and the business and operating results of our customers, suppliers and vendors may be significantly impacted by general economic, political and social conditions, pandemics, wars or terrorist activity, severe weather events and other natural disasters, geopolitical circumstances and events, such as the conflict in the Middle East, the war between Russia and Ukraine as well as ong…” |
| Supplier | Amazon (AMZN) | “We rely on information technology and other services, systems and platforms, including Amazon Web Services and certain other third-party platforms, and failures, errors, defects or disruptions therein could diminish our brand and reputation, subject us to” |
| Customer | NFL Enterprises | “The rising costs of sports rights, including without limitation in relation to our rights agreements with the NFL and the English and Scottish Football leagues (which were renewed in 2025 and 2024, respectively), means that we are required to pass on these higher costs to our customers.” |
Quoted from the company's 20-F filed Mar 17, 2026.
GENI analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.20 | $0.19 | +5.3% | $261.2M | 1 |
| Next quarter (ends Dec 2026) | $0.33 | $0.27 | +22.2% | $371.2M | 1 |
| Current fiscal year (ends Dec 2026) | $0.62 | $0.52 | +19.2% | $1.02B | 1 |
| Next fiscal year (ends Dec 2027) | $1.07 | $0.97 | +10.3% | $1.30B | 1 |
GENI options: expected move
Options price a move of about ±24.1% (±$1.58) by Nov 20, 2026, which includes earnings on Nov 3, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 87.7% | ±24.1% |
| Dec 18, 2026 | 56 | 78.3% | ±28.7% |
| Jan 15, 2027 | 84 | 74.5% | ±32.5% |
| Apr 16, 2027 | 175 | 74.2% | ±44.7% |
30-day implied volatility 75.8% vs 76.4% realized over the last 30 trading days. Put/call ratio (volume) 0.06. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 10:00 UTC)
| Price | USD 6.54 |
|---|---|
| Change | ▲ 1.71% (up) |
| Previous Close | USD 6.43 |
| Open | USD 6.39 |
| Day Range | USD 6.32 – 6.75 |
| 52-Week Range | USD 3.83 – 12.17 |
| Volume | 5,221,363 shares |
| Market Cap | $1.75B |
| Exchange | NYQ |
Technical Analysis (GENI)
Nexqual's technical model rates GENI "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 10:00 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.13 (neutral) |
| vs SMA50 | Below (USD 6.84) |
| MACD | -0.02 (negative) |
Analyst Ratings (GENI)
Wall Street analysts rate GENI "Buy" based on 21 analysts, with a mean price target of USD 10.83 (range USD 6–20), per Nexqual as of October 23, 2026 at 10:00 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 10.83 |
| High Target | USD 20 |
| Low Target | USD 6 |
| Buy / Hold / Sell | 18 / 3 / 0 |
Earnings (GENI)
| Next Earnings Date | 2026-11-03 |
|---|---|
| EPS Estimate | USD 0.2 |
| Revenue Estimate | $261.20M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.07 vs est 0.04 ▲ beat |
| 2026-03-31 | USD 0.02 vs est 0.01 ▲ beat |
| 2025-12-31 | USD -0.02 vs est 0.13 ▼ miss |
| 2025-09-30 | USD -0.04 vs est 0.07 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:00 UTC.
Financials & Fundamentals (GENI)
| Total Revenue | $790.23M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +64.70% |
| Gross Margin | +27.45% |
| Operating Margin | -12.40% |
| Profit Margin | -22.99% |
| ROE | -25.87% |
| Debt / Equity | 1.2 |
| Current Ratio | 0.97 |
| Total Cash | $155.08M |
| Total Debt | $821.01M |
Source: Nexqual, October 23, 2026 at 10:00 UTC.
Financial Health Score (GENI)
Nexqual rates Genius Sports Limited's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:00 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 27%, operating -12% (last 12 months) |
| Balance Sheet | Weak — $155M cash vs $821M debt |
| Cash Flow | Weak — Operating cash flow -$31M (TTM) |
| Efficiency | Critical — ROE -26%, ROA -4.6% |
Ownership (GENI)
| Insider Ownership | +9.09% |
|---|---|
| Institutional Ownership | +91.75% |
| Shares Outstanding | 267.63M |
| Float | 214.70M |
| Short % of Float | +15.54% |
Source: Nexqual, October 23, 2026 at 10:00 UTC.
Leadership (GENI)
Genius Sports Limited is led by Mark Adrian Locke, Co-Founder & CEO, per Nexqual as of October 23, 2026 at 10:00 UTC.
| Co-Founder & CEO | Mark Adrian Locke |
|---|---|
| CFO & Director | Bryan David Castellani |
| Chief Product & Technology Officer | Matt Fleckenstein |
| Chief Marketing Officer | Tony Marlow |
| Chief Commercial Officer & Director | Jack Alexander Davison |
Major Backers & Investors (GENI)
Notable institutional backers of Genius Sports Limited include Senvest Management LLC, Glenview Capital Management, Llc, Hood River Capital Management LLC, according to Nexqual as of October 23, 2026 at 10:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Senvest Management LLC | 6.45% |
| Glenview Capital Management, Llc | 5.48% |
| Hood River Capital Management LLC | 5.25% |
| Stephens Investment Management Group LLC | 4.34% |
| Shapiro Capital Management LLC | 4.01% |
| Frontier Capital Management Company LLC | 3.83% |
| Discovery Capital Management, LLC | 2.94% |
| Fidelity | 2.88% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.03% |
Source: Nexqual, October 23, 2026 at 10:00 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPRA | Opera Limited | USD 17.74 | ▼ 1.44% |
| DJT | Trump Media & Technology Group | USD 6.61 | ▼ 0.75% |
| WB | Weibo Corporation | USD 6.32 | ▼ 0.16% |
| WBTN | WEBTOON Entertainment Inc. | USD 9.5 | ▼ 3.46% |
| STUB | StubHub Holdings, Inc. | USD 6.1 | ▲ 3.21% |
| ATHM | Autohome Inc. | USD 20.4 | ▲ 2.26% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:00 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt